C-71980262, a novel small molecule against human papilloma virus-16 E6 (HPV-16 E6) with anticancer potency against cervical cancer: A computational guided in vitro approach
Author:
Open Access
- 1 January 2024
- journal article
- Vol. 27 (11) , 1389-1396
Abstract
Human papillomavirus-16 E6 (HPV-16 E6) forms a heterodimer complex to up-regulate the degradation of tumor suppressor protein p53 to promote cervical cancer. This study aims to identify a novel small molecule against E6 with anticancer efficacy against HPV-16, a prime high-risk serotype inducer for cervical cancer. Autodock-vina-based high-throughput virtual screening and atomistic molecular dynamic simulations were used for identification of targeted lead molecules. HPV-16 infected SiHa and CaSki cell lines were used to validate the lead compound in vitro. Proliferation of cancer cells was analyzed by MTT assay and flow cytometry was used to analyze target inhibition, apoptosis, and p53. High throughput virtual screening and molecular dynamic simulation identified C-71980262 as a lead candidate that could bind HPV-E6. Atomistic molecular dynamic simulation of E6 bound C-71980262 for 200 ns showed that the predicted ligand binding was stable with minimal energy expenditure, proposing the viability and veracity of the assessed molecule. C-71980262 inhibited the proliferation of SiHa and CaSki cells with GI50 values of 355.70 nM and 505.90 nM, respectively. The compound reduced HPV-16 E6 while inducing early and late-phase apoptosis in these cells. Treatment with C-71980262 increased the p53-positive populations in SiHa and CaSki cells. C-71980262 was identified as a novel lead molecule that could inhibit the HPV-16 E6 and increase p53 in cervical cancer cells. Further in vitro and in vivo validation is warranted to consolidate and corroborate this lead compound against HPV-induced cancer progression.Keywords
This publication has 40 references indexed in Scilit:
- Biology of Human Papillomavirus Infections in Head and Neck CarcinogenesisHead and Neck Pathology, 2012
- Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of TumorigenesisGenes & Cancer, 2011
- Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendmentsVirology, 2010
- Papillomaviruses in the causation of human cancers — a brief historical accountVirology, 2009
- Recent Advances in the Search for Antiviral Agents against Human PapillomavirusesAntiviral Therapy, 2007
- Human Papillomavirus and Cervical CancerClinical Microbiology Reviews, 2003
- The role of the E6-p53 interaction in the molecular pathogenesis of HPVOncogene, 1999
- The Role of E6AP in the Regulation of p53 Protein Levels in Human Papillomavirus (HPV)-positive and HPV-negative CellsJournal of Biological Chemistry, 1998
- Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.1992
- HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.The EMBO Journal, 1989